Washington University in St. Louis

A Gamma-Ray Flare from TXS 1508+572: Characterizing the Jet of a z = 4.31 Blazar in the Early Universe (2024) Gokus A, Böttcher M, Errando M, Kreter M, Heßdörfer J, Eppel F, Kadler M, et al. Journal article Long term variability of Cygnus X-1: VIII. A spectral-timing look at low energies with NICER (2024) König O, Mastroserio G, Dauser T, Méndez M, Wang J, García JA, Steiner JF, et al. Journal article A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits (2024) Wietek J, Nozownik A, Pulin M, Saraf-Sinik I, Matosevich N, Gowrishankar R, Gat A, et al. Journal article Astronomy’s climate emissions: Global travel to scientific meetings in 2019 (2024) Gokus A, Jahnke K, Woods PM, Moss VA, Ossenkopf-Okada V, Sacchi E, Stevens AR, et al. Journal article Vulnerabilities in social anxiety: Integrating intra- and interpersonal perspectives (2024) Ginat-Frolich R, Gilboa-Schechtman E, Huppert JD, Aderka IM, Alden LE, Bar-Haim Y, Becker ES, et al. Journal article, Review article Rapid variability of Markarian 421 during extreme flaring as seen through the eyes of XMM-Newton (2024) Gokus A, Wilms J, Kadler M, Dorner D, Nowak MA, Kreikenbohm A, Leiter K, et al. Journal article Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force (2024) Prasad V, Koumarianou A, Denecke T, Sundin A, Deroose CM, Pavel ME, Christ E, et al. Journal article Twenty-five years of primate research in the Ndoki forest, Republic of Congo (2024) Morgan D, Stephan C, Sanz C Journal article ALK -rearranged Mesenchymal Neoplasms With Prominent Foamy/Pseudolipogenic Cell Morphology : Expanding the Phenotypic Spectrum of ALK Fusion Neoplasms and Report of Novel Fusion Partners. (2024) Agaimy A, Stöhr R, Fisher C, Chrisinger JS, Demicco EG, Tögel L, Michal M, Michal M Journal article A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024) Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al. Journal article